Syensqo SA (SYENS) Fair Value & Analysis
Basic Materials · BE · Market cap €8.0B
Fair value as of: Aug 13, 2026
From 14 valuation models · updated today
Fair value updated Aug 13, 2026, revised from €39.77 to €58.96 (+48.3%) since Aug 6, 2026. Share price +20.3% over the past month.
Below-average quality, and screening another 28% overvalued on our models.
What matters now
- The model range is unusually wide (€26.26 to €105.04). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid but not exceptional quality (47/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (3 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
32‑month range €41.99 – €98.25 · fair‑value band €26.26 – €105.04 · the €82.45 price screens above the €58.96 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Syensqo SA (SYENS) currently trades at €82.45, while our model-based Fair Value estimate is €58.96, implying the stock looks roughly 28.5% overvalued today. The Quality Score stands at 47/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Syensqo SA generated revenue of €5.9B at a net margin of 0.1%. Revenue declined 6.9% year over year. It earns a return on equity of -0.8%. Net debt stands at €2.1B. Fundamentals as of Aug 13, 2026
Our scenario range runs from €26.26 (bear case) to €105.04 (bull case); at €82.45, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 103% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -53% fair-value upside, at -28%, SYENS screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 14 models by family
Widest divergence: Multiples (€40.31) versus Earnings-Based (€12.68). Highest evidence: Growth DCF (80).
Notify me when SYENS reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 46 · Market factors (momentum, volatility) 60
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Syensqo SA/NV, a chemical company, engages in the research, development, and production of advanced materials for industrial and consumer applications worldwide. The company operates through the Materials, Performance & Care, and Other Solutions segments.
Full company description
Syensqo SA/NV, a chemical company, engages in the research, development, and production of advanced materials for industrial and consumer applications worldwide. The company operates through the Materials, Performance & Care, and Other Solutions segments. It offers amine ether, amines, fatty amines, and specialty amines; antioxidants and stabilizers; composites; flavors and fragrances, including vanillin, ethylvanillin, natural vanillin, and cyclopentanone; lithium derivatives; diphenols and hydrocarbon monomers; and phosphorus specialties. The company also provides biobased polymers, inverse emlusion polymers, monomers, specialty monomers, and synthetic polymers; solvents comprising green solvents, flame retardants, and hydrocarbon; specialty chemicals, such as nitric acid; specialty polymers that include aromatic polyamides, aromatics, sulfones, fluorinated fluids, fluoropolymers, high performance polyester, polyethylene, polyolefin, and polyvinylidene chloride; and amphoteric, anionic, blend, cationic, and non-ionic surfactants. It serves the aerospace, automotive, agriculture, batteries, building, consumer goods, electronics, food, green hydrogen, healthcare, industrial, resources, environment, and energy sectors, as well as renewable materials and biotechnology markets. Syensqo SA/NV was founded in 1863 and is headquartered in Brussels, Belgium.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Syensqo SA reported revenue of €5.8B in FY2026 versus €6.0B in FY2022, a compound −1.1%/yr. Reported net income was −€62.0M in FY2026.
SYENS screens 28% overvalued. Compare with BASF SE →
Earlier news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Syensqo second quarter 2026 results
- Syensqo - Participation notification by BlackRock Inc.
- A Look At Syensqo (ENXTBR:SYENS) Valuation After The Performance And Care Segment Review
- Syensqo launches strategic review of its Performance & Care segment
Peer Group
Chemicals · 332 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Chemicals median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| BASF SE BASN | 1,034 MXN | 467.04 MXN | -55% |
| PT Barito Pacific Tbk, BRPT | 1,950 IDR | 1,608 IDR | -18% |
| LG Chem, Ltd 051910 | 275,500 KRW | 587,755 KRW | +113% |
| PTT Global Chemical Public Company PTTGC | 38.50 THB | 18.21 THB | -53% |
| 542812 542812 | ₹4,709 | ₹791.05 | -83% |
| Navin Fluorine International Limited NAVINFLUOR | ₹8,357 | ₹2,146 | -74% |
| Kansai Nerolac Paints Limited 500165 | ₹209.25 | ₹80.51 | -62% |
| Deepak Nitrite Limited DEEPAKNTR | ₹1,718 | ₹679.17 | -60% |
| KCC Corporation 002380 | 454,000 KRW | 1,763,304 KRW | +288% |
| Deepak Fertilisers And Petrochemicals Corporation DEEPAKFERT | ₹1,456 | ₹990.72 | -32% |
Compare Syensqo SA with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Syensqo SA (SYENS) overvalued or undervalued?
What is the fair value of SYENS?
What is the quality score of SYENS?
What is the revenue of Syensqo SA (SYENS)?
What is the net profit margin of SYENS?
Does Syensqo SA pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Syensqo SA and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.